Skip to content

Clinical trials

Gastrointestinal Stromal Tumors trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastrointestinal Stromal Tumors Country / region: South Korea Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20074
20094
20102
20113
20122
20131
20142
20152
20162
20171
20182
20193
20223
20234
20241
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Recruiting10
Active, not recruiting3
Terminated2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Asan Medical Center16
Novartis Pharmaceuticals5
Bayer3
Pfizer3
Blueprint Medicines Corporation2
Deciphera Pharmaceuticals, LLC2
GlaxoSmithKline2
Chong Kun Dang Pharmaceutical1
Cogent Biosciences, Inc.1
Dong-A ST Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastrointestinal Stromal Tumors41
Biliary Tract Neoplasms4
Breast Neoplasms3
Carcinoma, Hepatocellular3
Gastrointestinal Neoplasms3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive3
Neoplasm Metastasis3
Stomach Neoplasms3
Cholangiocarcinoma2
Colorectal Neoplasms2

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.